EAGLE POINT STRATEGIES LLC

Registrant on federal lobbying filings · filed 2025 to 2026

$150,000 Income reported

3 Clients represented

14 Filings counted

0 Former members lobbying

Income is the fees this registrant reported being paid to lobby. Everything on this page is grouped by the registrant's LDA id (401108457), not by name.

Clients 3

SMALL BUSINESS CONSULTING CORPORATION $80,000 7 filings
OBJECT PHARMA $60,000 6 filings
NEXA CAPITAL PARTNERS LLC $10,000 1 filing

Lobbyists named 1

CLAY WHITE 14 filings · through 2026 Chief of Staff, Leg Director - Congressman Chris Stewart; Leg Director, Leg Asst - Congressman Jason Chaffetz

A lobbyist who previously held a covered government position must disclose it. We flag the ones whose name resolves to a member of Congress and link the ones still in our roster. The revolving door collects them across every firm.

Reported by year 2 years

2026 $50,000 4 filings
2025 $100,000 10 filings

Issues lobbied 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 2

HOUSE OF REPRESENTATIVES 13
SENATE 13

Recent filings 14 total

Q2

SMALL BUSINESS CONSULTING CORPORATION

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $15,000 income · posted Jul 8, 2026

View → Q2

OBJECT PHARMA

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $10,000 income · posted Jul 8, 2026

View → Q1

SMALL BUSINESS CONSULTING CORPORATION

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $15,000 income · posted Apr 13, 2026

View → Q1

OBJECT PHARMA

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $10,000 income · posted Apr 13, 2026

View → Q4

SMALL BUSINESS CONSULTING CORPORATION

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $15,000 income · posted Jan 14, 2026

View → Q4

OBJECT PHARMA

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $10,000 income · posted Jan 14, 2026

View → Q3

SMALL BUSINESS CONSULTING CORPORATION

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $15,000 income · posted Oct 13, 2025

View → Q3

OBJECT PHARMA

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $10,000 income · posted Oct 13, 2025

View → Q2

SMALL BUSINESS CONSULTING CORPORATION

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $15,000 income · posted Jul 12, 2025

View → Q2

OBJECT PHARMA

2nd Quarter (Apr 1 - June 30) 2025 · House · Senate · $10,000 income · posted Jul 12, 2025

View → Q1

SMALL BUSINESS CONSULTING CORPORATION

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $5,000 income · posted Apr 9, 2025

View → Q1

OBJECT PHARMA

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $10,000 income · posted Apr 9, 2025

View → RR

SMALL BUSINESS CONSULTING CORPORATION

1st Quarter (Jan 1 - Mar 31) 2025 · posted Apr 2, 2025

View → 1T

NEXA CAPITAL PARTNERS LLC

1st Quarter (Jan 1 - Mar 31) 2025 · House · Senate · $10,000 income · posted Apr 2, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.